Invention Grant
- Patent Title: Kinase modulators
-
Application No.: US16557553Application Date: 2019-08-30
-
Publication No.: US11858907B2Publication Date: 2024-01-02
- Inventor: Meyyappan Muthuppalaniappan , Srikant Viswanadha , Govindarajulu Babu , Swaroop K. Vakkalanka
- Applicant: Rhizen Pharmaceuticals SA
- Applicant Address: CH La Chaux-de-Fonds
- Assignee: RHIZEN PHARMACEUTICALS AG
- Current Assignee: RHIZEN PHARMACEUTICALS AG
- Current Assignee Address: CH Basel
- Agency: Blank Rome LLP
- Priority: IN 90CHE2009 2009.11.05 IN 29CHE2010 2010.05.24
- Main IPC: C07D311/34
- IPC: C07D311/34 ; C07D519/00 ; C07D311/36 ; C07D405/06 ; C07D487/04 ; A61K31/437 ; A61K31/52 ; A61K31/5377 ; A61K45/06 ; C07D413/10 ; C07D413/14 ; C07D471/04 ; C07D473/34 ; A61K31/4178 ; A61K31/4184 ; A61K31/519 ; C07D473/38 ; A61K31/352 ; A61K31/522 ; C07D473/08 ; C07D473/40
Abstract:
The present invention provides PI3K protein kinase modulators of Formula (I)
wherein R, n, R1, R2, L1, Cy1 and Cy2 are as defined herein, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
wherein R, n, R1, R2, L1, Cy1 and Cy2 are as defined herein, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
Public/Granted literature
- US20200239427A1 NOVEL KINASE MODULATORS Public/Granted day:2020-07-30
Information query
